AF and HF - Ablation and AF Management in HF Patients

Description

This session will include presentations and discussions in the field of AF ablation in the context of heart failure.

Learning Objectives

Describe the state of evidence and role of rate vs rhythm control in managing patients with AF and heart failure.
Summarize patient selection for catheter ablation in heart failure (HFrEF and HFpEF).
Outline the role of ongoing medical therapy in patients who have undergone successful ablation for AF mediated cardiomyopathy.

Session Chair(s)

Douglas Packer, MD
Kevin Thomas, MD

Presentation

AF and HFrEF: Rate vs Rhythm Control
Presenter(s): Sandeep Prabhu, MBBS, PhD

Patient Selection and Ablation Strategies in Heart Failure
Presenter(s): Nassir F. Marrouche, MD

Withdrawal of Guideline-directed Medical Therapy Following AF Ablation
Presenter(s): Elizabeth S. Kaufman, MD

AF Ablation in HFpEF: Ready for Prime Time or Do We Need More Evidence?
Presenter(s): Scott C. Brancato, MD

Disclosures

Sandeep Prabhu:

Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Membership on Advisory Committees or Review Panels)

Nassir Marrouche:

Nothing Relevant to Disclose

Elizabeth Kaufman:

Janssen Pharmaceuticals (Research (Contracted Grants for PIs and Named Investigators only) - Research)

Scott Brancato:

Nothing Relevant to Disclose

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.

Education Framework

Supraventricular Tachyarrhythmias
-- AFib and Flutter - Catheter Ablation
-- 142. Know the indications, contraindications, expected outcomes and complications associated with catheter ablation of atrial fibrillation and flutter, including during pregnancy.

Summary


Availability:	No future session


Cost:	FREE


Credit Offered:	No Credit Offered

Recommended

Abstract Catalog 2025: ePosters

FREE